MG
BHC icon

Meritage Group’s Bausch Health BHC Stock Holding History

Meritage Group’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,344,024
Closed -$240M – 28
2015
Q3 		$240M Buy
1,344,024
+1,457
+0.1% +$340K 5.42% 8
2015
Q2 		$298M Sell
1,342,567
-1,403
-0.1% -$311K 6.68% 3
2015
Q1 		$267M Buy
1,343,970
+259,666
+24% +$46.1M 6.47% 3
2014
Q4 		$155M Sell
1,084,304
-497,347
-31% -$66.9M 3.24% 15
2014
Q3 		$208M Buy
1,581,651
+347
+0% +$41.4K 3.98% 9
2014
Q2 		$199M Buy
1,581,304
+207,737
+15% +$26.5M 4.07% 7
2014
Q1 		$181M Sell
1,373,567
-155,036
-10% -$21.2M 4.24% 11
2013
Q4 		$179M Buy
1,528,603
+343,374
+29% +$37.6M 4.63% 10
2013
Q3 		$124M Hold
1,185,229
– – 3.52% 14
2013
Q2 		$102M Buy
+1,185,229
New +$93.4M 2.97% 18

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Meritage Group's BHC Position: Q4 2015 in Review

Meritage Group sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 1,344,024 shares — an estimated $240M sold.

Meritage Group first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $298M in Q2 2015. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Meritage Group reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Meritage Group sold 1,344,024 Bausch Health shares in Q4 2015, an estimated $240M.
  • Meritage Group first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Meritage Group's Bausch Health position peaked at $298M in Q2 2015.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Meritage Group's 13F filing for Q4 2015, filed 12 Feb 2016.